Open Access

Unusual manifestations of acute Q fever: autoimmune hemolytic anemia and tubulointerstitial nephritis

  • Serdal Korkmaz1, 4Email author,
  • Nazif Elaldi2,
  • Mansur Kayatas1,
  • Mehmet Sencan1 and
  • Esin Yildiz3
Annals of Clinical Microbiology and Antimicrobials201211:14

https://doi.org/10.1186/1476-0711-11-14

Received: 4 January 2012

Accepted: 18 May 2012

Published: 18 May 2012

Abstract

Q fever is a worldwide zoonotic infection that caused by Coxiella burnetii, a strict intracellular bacterium. It may be manifested by some of the autoimmune events and is classified into acute and chronic forms. The most frequent clinical manifestation of acute form is a self-limited febrile illness which is associated with severe headache, muscle ache, arthralgia and cough. Meningoencephalitis, thyroiditis, pericarditis, myocarditis, mesenteric lymphadenopathy, hemolytic anemia, and nephritis are rare manifestations. Here we present a case of acute Q fever together with Coombs’ positive autoimmune hemolytic anemia (AIHA) and tubulointerstitial nephritis treated with chlarithromycin, steroids and hemodialysis. Clinicians should be aware of such rare manifestations of the disease.

Keywords

Q fever Pneumonia Autoimmune hemolytic anemia Tubulointerstitial nephritis

Background

Q fever is a worldwide zoonosis caused by Coxiella burnetii, a strict intracellular bacterium. Human infection results mainly from infected aerosols generated by farm animals when they give birth or abort. The disease is classified into acute and chronic forms. Chronic form is generally associated with endocarditis, osteomyelitis, infected vascular aneurysms, or infected intravascular prostheses [1]. Acute Q fever often presents either as a self-limiting flu-like illness, hepatitis, or pneumonia. The most frequent clinical manifestation of acute form is a self-limited febrile illness which is associated with severe headache, muscle ache, arthralgia and cough [2]. Other rare manifestations are seizure and coma, meningoencephalitis, thyroiditis, pericarditis, myocarditis, mesenteric lymphadenopathy, pancreatitis, hemophagocytosis, hemolytic anemia, transient hypoplastic anemia, and epididymoorchitis [3]. Here we present a case of acute Q fever together with Coombs’ positive AIHA and tubulointerstitial nephritis treated with chlarithromycin, steroids and hemodialysis.

Case presentation

A previously healthy 39-year-old man who was an officer in a city hospital presented with a 10-day history of fever, chills, fatigue, sweats, and muscle aches. He noted no complaints of cough and sputum but dyspnea and jaundice which began three days ago before presentation and gradually worsening over 24–48 hrs. He had no history of exposure to an animal and travel to rural areas. His temperature was 390C (102.20F), his pulse was 96 beats/min, his respiration rate was 24 breaths/min, his systolic blood pressure was 110 mmHg, and his oxygen saturation was 96% on room air. The patient seemed icteric and lung auscultation showed bibasilar crackling. Findings of additional examination were unremarkable. Arterial blood gas analysis revealed a marked respiratory alkalosis (elevated pH and marked decline in pCO2) and mild hypoxemia (pO2, 75 mm Hg).

The hemoglobin concentration was 4.4 g/dL, WBC count was 24 X 103cells/μL and platelet count was normal. Blood film examination showed 90% of neutrophils with toxic granulations and erythrocyte morphology with hypochromia, anisocytosis and spherocytosis. The levels of blood urea nitrogen (BUN), creatinine, electrolytes, vitamin B12, folate and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were normal. The serum lactate dehydrogenase (LDH) level was 414 U/L (normal range, 125–240 U/L) and total bilirubin was 5.8 mg/dL (normal range, 0.3-1.2 mg/dL) with a rate of 3.0 mg/dL indirect bilirubin. The corrected reticulocyte count was 4% (normal range, 0.5-2.5%). A routine urinalysis was normal and the fecal occult blood test was negative. The erythrocyte sedimentation rate (ESR) was 100 mm/h, and the C-reactive protein (CRP) level was 272 mg/L (normal value, <8 mg/L). Chest radiography showed multiple pulmonary infiltrates and an additional CT of thorax widespread patchy ground-glass opacities throughout both lungs suggesting acute interstitial or viral pneumonia and bilateral pleural effusion (Figure 1a and Figure1b). The direct Coombs’ test (antiglobulin test) for explaining of hemolysis was positive. The patient was admitted to the intensive care room, and he began receiving intravenous fluids, empirical ampicillin/sulbactam intravenously plus oral clarithromycin for clinical diagnosis of community acquired pneumonia, and methylprednisolon intravenously (1 mg/Kg daily) for controlling hemolytic process.
Figure 1

a) Multiple pulmonary infiltrates. b) Widespread patchy ground-glass opacities throughout both lungs and bilateral pleural effusion.

A total of 4 unites of erythrocyte suspension were administered in 24 hours and the hemoglobin concentration increased to 8.0 g/dL. Despite the clinical situation of him was good, the patient's laboratory values worsened on the second day of admittance. The BUN rose to the level of 43 mg/dL (normal range, 5–25 mg/dL) and the creatinine rose to the level of 3.4 mg/dL (normal range, 0.7-1.2 mg/dL). The AST level was 1388 U/L (normal range, 5–40 U/L) and the ALT level was 832 U/L (normal range, 5–54 mg/dL). Total bilirubin level increased to 9.4 mg/dL (indirect content, 4.1 mg/dL), and the LDH level to 4822 IU/L. The total creatine kinase level was 1515 U/L (normal range, 38–176 U/L). Performed sequential electrocardiograms and echocardiography test showed no cardiac pathology. Thyroid function tests were within normal values. A serum sample for diagnosing of Hantavirus infection, Crimean-Congo hemorrhagic fever virus (CCHFV) infection, and acute Q fever and a throat swab specimen for diagnosing of H1N1 influenza were sent to the Refik Saydam Hifzissihha Institute, Ankara, Turkey. Serological markers indicating acute infection with Epstein-Barr virus, cytomegalovirus, herpes simplex virus, parvovirus, varicella zoster virus, mumps virus, measles virus, and rubella virus were all negative. The detailed viral hepatitis markers andBrucella-specific Wright tube agglutination test were also negative. The blood and urine cultures for bacteria yielded no growth.

His blood hemoglobin concentration decreased again to 5 gr/dL on the 3rd day and cold agglutinin test was found to be negative on the same day. The blood creatinine rose to the level of 8.4 mg/dL on the day 4th, and anuria developed. After evaluation, it was decided to take the patient in hemodialysis treatment 3 times a week. A percutaneous renal biopsy on the day 12th demonstrated acute tubulointerstitial nephritis (TIN, Figure 2). Serologic and virologic analyses with ELISA and real time-PCR method for Hantavirus infection, CCHFV and PCR method for H1N1 influenza were negative. Serum sample was found to be positive against C. burnetii by immunofluorescence assay (IFA) and indicated an acute Q fever infection with the titer of 1:512 for IgG, 1:64 for IgM against phase II and a negative serology against phase I antigen. The patient continued receiving antibiotics and hemodialysis treatment for 14 days. He became afebrile after 5 days of antibiotic and steroid treatment, his clinical condition improved in 10 days, AST and ALT returned to normal levels within 15 days. The blood creatinine returned to normal levels 16 days after hemodialysis started and then hemodialysis treatment no longer needed. A total of 18 units of erythrocyte suspension were administered during the hospitalization period and the blood hemoglobin concentration was 10.9 g/dL on the 16th day of admission. Total bilirubin returned to normal levels after 21 days of admission. The pulmonary infiltrates improved after 21 days of antibiotic therapy. Steroid therapy was continued for 3 months and discontinued by reducing the dose over time. The patient improved without any complications and he was uneventful after 6 months of follow up.
Figure 2

Histologic findings in the kidney demonstrating focal tubular atrophy, interstitial edema and infiltration with lymphocytes and eosinophils, and hyalen cylendirs (hematoxylin and eosin stain; original magnification, X20).

Discussion

Pneumonia and hepatitis are frequently seen in acute Q fever and there are two additional manifestations in our patient: TIN with acute renal dysfunction and Coombs’ positive AIHA. Glomerulonephritis, attributed to immune-complex deposition and a well-recognized feature of chronic form of Q fever, is described less frequently in acute form [4]. Since a small number of cases have reviewed systematically, the incidence of renal complication in Q fever is unknown. In a recent retrospective study performed in 54 acute Q fever patients have demonstrated 33% of patients having renal failure [5]. Acute TIN is an important cause of acute renal failure, and often associated with use of drugs and various infections. Those most commonly implicated are antibiotics (penicillins, cephalosporins, sulfonamides and rifampicin) and non-steroidal anti-inflammatory drugs although cases of TIN have been linked to many medications [6]. Clarithromycin has also been reported previously as an aetiological factor in TIN [7]. Despite using two aetiologic agents (ampicillin and clarithromycin) in the patient for developing TIN, we believe that it has occurred due to Q fever. Firstly, the patient had a history of using any medications before referring to the hospital and he received those antibiotics only for a day before rising blood BUN and creatinine levels. These are unlikely to have contributed to the renal complication. Secondly, extremely lower hemoglobin concentration, a higher bilirubin level and a positive direct Coombs’ test on admittance suggesting strongly autoimmune events. The other mechanism for renal involvement by an infection agent is via direct parenchyma infiltration or a systemic inflammatory response against the bacteria. Rickettsial organisms in the tubular epithelium glomeruli and interstitium of the kidney in a fatal case of Q fever have been demonstrated [8].

Apart from the present case, there are only a few case reports concerning renal complications associated with acute Q fever in the literature in English. A case of acute renal failure in a male patient with acute Q fever who had a febrile illness, pneumonia, and a skin rash was described [9]. The authors reported that there were proteinuria and hematuria in the patient but renal biopsy was not done to confirm suspected glomerulonephritis. They stated that renal failure improved in the patient without dialysis treatment. Korman et al. [10] also reported a male case of acute diffuse proliferative and exudative glomerulonephritis, resolving spontenously, associated with acute Q fever. Antiphospholipid antibodies may also accompanied with acute renal failure in Q fever. Tolosa-Vilella et al. [11] described a case of acute Q fever with mesangioproliferative glomerulonephritis and immunglobulin (Ig) G antibodies to cardiolipin and lupus anticoagulant in acute-phase serum samples. A recent case report has noticed a female patient with postinfectious glomerulonephritis associated with acute form of the disease [12]. Sometimes renal failure in Q fever may not to be related with acute glomerulonephritis or TIN as in our case. A case of acute Q fever associated by extreme rhabdomyolysis and consecutive acute renal failure treated with continuous venovenous hemodiafiltration was presented [13].

Interaction of C. burnetii with the host's immune system is complex and still poorly understood. Immune control of C. burnetii is T-cell dependent but does not lead to C. burnetii eradication. The organism is able to grow and multiply within phagolysosomes [14]. The expression of antigens specific to C. burnetii in the membranes of infected host cells [15] supports the hypothesis that infected cells are detected by the immune system and lysed by antibody-dependent cellular cytotoxicity by monocytes and other effector cells. Specific immunoglobulins are secreted following infections. IgG is mainly directed against phase II antigen, whereas IgM is directed against both phase I and II cells [16]. Chronic infections are believed to be a result of immunological reactions and/or defects [14, 16]. During chronic Q fever, the immune response is ineffective and may also be harmful, causing leucocytoclastic vasculitis and glomerulonephritis [16]. A variety of autoantibodies have been described in Q fever, including antismooth muscle and antimitochondrial antibodies, ANA, rheumatoid factor, and cold agglutinins [17]. All of these autoantibodies were negative in our case.

Seroconversion to C. burnetii develops usually 7–15 days after onset of clinical symptoms, and antibodies against phase I and phase II appear in the blood. The presence of both an anti-phase II IgG titer of ≥1:200 and IgM titer of ≥1:50 is 100% predictive of acute Q fever. However, such results are observed only in 10% of patients during the second week following the onset of symptoms [18]. A clinical and laboratory study which was performed in 22 patients with acute Q fever showed that fifth day serum samples had a sensitivity of 80% in the diagnosis of acute Q fever and sixth to eleventh day serum samples had a sensitivity of 83% by the IFA technique [19]. However, cross-reactivity with other infectious agents such as Chlamydia Bartonella and Legionella species has been observed especially in chronic Q fever [2022]. Two hundred and eleven serum samples of acute and chronic Q fever by the IFA test revealed that four serum samples (1.9%) had antibodies against both C. burnetii and Legionella pneumophila[20]. More than 50% of patients with chronic Q fever had sera containing cross-reacting antibodies to Bartonella henselae or Bartonella quintana[21]. It has been proposed that a differential diagnosis among the infections is easily established when quantitative antibody titers against both anti-phase I and anti-phase II C. burnetii antigens are determined [18]. Because of its protean manifestations, leptospirosis mimics many other infectious diseases including Q fever with pneumonia and it must also be differentiated from Q fever [23].

Various mechanisms are responsible for hemolytic anemia in the course of an infection including direct invasion of red blood cell by the pathogen, toxin production, mechanical effects and immune-mediated hemolysis. Immune mechanisms can also be divided into autoimmune, antigen-antibody complexes and polyagglutination reactions [24]. The patient was anemic on admittance and totally 18 units of erythrocyte suspension were administered during the hospitalization period. The negativity of cold agglutinins, positivity of direct and indirect Coombs’ tests and a higher reticulocyte count suggested strongly that AIHA occurred due to autoimmune events needing steroid therapy. Warm and cold agglutinins can occur during the infectious and non-infectious events and the most of AIHAs are caused by warm antibodies, whereas cold antibodies are less commonly detected. The direct Coombs’ test is the first step in diagnosing of AIHA, and the distinction of warm and cold agglutinins can help in the differential diagnosis of the cause of AIHA. In warm antibody AIHA, standard first line therapy is corticosteroids with or without high dose of immunoglobulin, whereas splenectomy is considered second-line therapy. Patients with cold agglutinins are refractory to steroids and splenectomy [25]. Since the warm and cold agglutinin tests were not available in our institution, these agglutinins could not be identified in the patient for the explaining of the cause of AIHA. Because responded well to the corticosteroid therapy, we think the cause of AIHA is warm agglutinins.

Despite the recommended therapy regimen for Q fever is doxycycline, clarithromycin is a reasonable treatment for acute Q fever [26]. The corticosteroid therapy had two useful effects on our patient. First, it eliminated the autoimmune hemolytic process and therefore, the patient did not need any blood transfusions Second, being useful for inflammatory events, it relieved the renal dysfunction which caused by acute TIN. Additionally, hemodialysis program contributed to control of uremic symptoms in the patient.

Conclusions

Acute Q fever may be presented as both renal dysfunction and AIHA. Therefore, the clinicians should be aware of such manifestations. Establishment of diagnosis and treatment procedure is simple and is mentioned above. Only it must be done cautiously.

Consent

Written informed consent was obtained from the patient for publication of this Case report and any accompanying images.

Declarations

Acknowledgements

We would like to thank our colleagues from the Refik Saydam Hifzissihha Institute, Ankara, Turkey, for their laboratory support and to Yusuf Tutar for language editing.

Authors’ Affiliations

(1)
Department of Internal Medicine, Faculty of Medicine, Cumhuriyet University
(2)
Department of Infectious Diseases and Clinical Bacteriology, Faculty of Medicine, Cumhuriyet University
(3)
Department of Pathology, Faculty of Medicine, Cumhuriyet University
(4)
Department of Internal Medicine, Cumhuriyet University, Faculty of Medicine

References

  1. Parker NR, Barralet JH, Bell AM: Q fever. Lancet. 2006, 367: 679-688. 10.1016/S0140-6736(06)68266-4View ArticlePubMedGoogle Scholar
  2. Tissot-Dupont H, Raoult D: Q fever. Infect Dis Clin North Am. 2008, 22: 505-514. 10.1016/j.idc.2008.03.002View ArticlePubMedGoogle Scholar
  3. Marrie TJ, Raoult D: Q fever–a review and issues for the next century. Int J Antimicrob Agents. 1997, 8: 145-161. 10.1016/S0924-8579(96)00369-XView ArticlePubMedGoogle Scholar
  4. Turck WPG, Howitt G, Turnberg LA: Chronic Q fever. Q J Med. 1976, 45: 193-217.PubMedGoogle Scholar
  5. Ruiz Seco MP, Lopez Rodriguez M, Estebanez Munoz M: Q fever: 54 new cases from a tertiary hospital in Madrid. Rev Clin Esp. 2011, 211: 240-244. 10.1016/j.rce.2011.01.003View ArticlePubMedGoogle Scholar
  6. Torpey N, Barker T, Ross C: Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit. Nephrol Dial Transplant. 2004, 19: 1441-1446. 10.1093/ndt/gfh137View ArticlePubMedGoogle Scholar
  7. Audimoolam VK, Bhandari S: Clarithromycin-induced granulomatous tubulointerstitial nephritis. Nephrol Dial Transplant. 2006, 21: 2654-2655. 10.1093/ndt/gfl172View ArticlePubMedGoogle Scholar
  8. Whittick JW: Necropsy findings in a case of Q fever in Britain. BMJ. 1950, 1: 979- 10.1136/bmj.1.4660.979View ArticlePubMedPubMed CentralGoogle Scholar
  9. Morovic M, Dzelalija B, Novakovic S, Stankovic S, Dujella J: Acute renal failure as the main complication of acute infection with Coxiella burnetii. Nephron. 1993, 64: 335- 10.1159/000187348View ArticlePubMedGoogle Scholar
  10. Korman TM, Spelman DW, Perry GJ, Dowling JP: Acute glomerulonephritis associated with acute Q fever: case report and review of the renal complications of Coxiella burnetii infection. Clin Infect Dis. 1998, 26: 359-364. 10.1086/516308View ArticlePubMedGoogle Scholar
  11. Tolosa-Vilella C, Rodriguez-Jornet A, Font-Rocabanyera J, Andreu-Navarro X: Mesangioproliferative glomerulonephritis and antibodies to phospholipids in a patient with acute Q fever: case report. Clin Infect Dis. 1995, 21: 196-198. 10.1093/clinids/21.1.196View ArticlePubMedGoogle Scholar
  12. Pattullo V, Guindi M, Herzenberg A, Scholey J, Wong F: Unexpected renal and liver failure. Am J Med. 2010, 123: 799-801. 10.1016/j.amjmed.2010.06.001View ArticlePubMedGoogle Scholar
  13. Ljutic D, Radovnikovic G, Kurir TT: Acute renal failure associated with rhabdomyolysis in acute Q Fever. Ren Fail. 2007, 29: 743-746. 10.1080/08860220701460178View ArticlePubMedGoogle Scholar
  14. Koster FT, Goodwin JS, Williams JC: Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit. J Immunol. 1985, 135: 1067-1072.PubMedGoogle Scholar
  15. Jerrels TR: Mechanisms of immunity to rickettsia species and coxiella burnetii. The biology of the rickettsiae. Edited by: Walker DH. 1988, 79-100. CRC Press, Boca Raton, FL,Google Scholar
  16. Raoult D, Marrie T, Mege J: Natural history and pathophysiology of Q fever. Lancet Infect Dis. 2005, 5: 219-226. 10.1016/S1473-3099(05)70052-9View ArticlePubMedGoogle Scholar
  17. Fournier PE, Marrie TJ, Raoult D: Diagnosis of Q fever. J Clin Microbiol. 1998, 36: 1823-1834.PubMedPubMed CentralGoogle Scholar
  18. Maurin M, Raoult D: Q fever. Clin Microbiol Rev. 1999, 12: 518-553.PubMedPubMed CentralGoogle Scholar
  19. Boden K, Wagner-Wiening C, Seidel T: Diagnosis of acute Q fever with emphasis on enzyme-linked immunosorbent assay and nested polymerase chain reaction regarding the time of serum collection. Diagn Microbiol Infect Dis. 2010, 68: 110-116. 10.1016/j.diagmicrobio.2010.06.001View ArticlePubMedGoogle Scholar
  20. Finidori JP, Raoult D, Bornstein N, Fleurette J: Study of cross-reaction between Coxiella burnetii and Legionella pneumophila using indirect immunofluorescence assay and immunoblotting. Acta Virol. 1992, 36: 459-465.PubMedGoogle Scholar
  21. La Scola B, Raoult D: Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii. J Clin Microbiol. 1996, 34: 2270-2274.PubMedPubMed CentralGoogle Scholar
  22. Wilson AP, Handler CE, Ridgway GL, Treharne J, Walker JM, Mangham DC: Coxiella burneti endocarditis in a patient with positive chlamydial serology. J Infect. 1992, 25 (Suppl 1): 111-118.View ArticlePubMedGoogle Scholar
  23. Hartskeerl RA, Collares-Pereira M, Ellis WA: Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 2011, 17: 494-501. 10.1111/j.1469-0691.2011.03474.xView ArticlePubMedGoogle Scholar
  24. Dhaliwal G, Cornett PA, Tierney LM: Hemolytic anemia. Am Fam Physician. 2004, 69: 2599-2606.PubMedGoogle Scholar
  25. Valent P, Lechner K: Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review. Wien Klin Wochenschr. 2008, 120: 136-151. 10.1007/s00508-008-0945-1View ArticlePubMedGoogle Scholar
  26. Gikas A, Kofteridis DP, Manios A, Pediaditis J, Tselentis Y: Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob Agents Chemother. 2001, 45: 3644-3646. 10.1128/AAC.45.12.3644-3646.2001View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Korkmaz et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement